Machine learning developed a programmed cell death signature for predicting prognosis and immunotherapy benefits in lung adenocarcinoma

BACKGROUND: Lung cancer is the leading cause of cancer-related deaths worldwide with poor prognosis. Programmed cell death (PCD) plays a crucial function in tumor progression and immunotherapy response in lung adenocarcinoma (LUAD). METHODS: Integrative machine learning procedure including 10 method...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Dongxiao, Wang, Liangbin, Zhang, Yunqiang, Shi, Ke, Shen, Yaxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511492/
https://www.ncbi.nlm.nih.gov/pubmed/37722290
http://dx.doi.org/10.1016/j.tranon.2023.101784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511492/
https://www.ncbi.nlm.nih.gov/pubmed/37722290
http://dx.doi.org/10.1016/j.tranon.2023.101784

Ejemplares similares